PY2139366A - Receptores de motivos de lisina - Google Patents

Receptores de motivos de lisina

Info

Publication number
PY2139366A
PY2139366A PY202102139366A PY2139366A PY2139366A PY 2139366 A PY2139366 A PY 2139366A PY 202102139366 A PY202102139366 A PY 202102139366A PY 2139366 A PY2139366 A PY 2139366A PY 2139366 A PY2139366 A PY 2139366A
Authority
PY
Paraguay
Prior art keywords
domain
lysm1
present
receptors
modifications
Prior art date
Application number
PY202102139366A
Other languages
English (en)
Inventor
Kasper Rojkjaer Andersen
Christina Krönauer
Mette Laursen
Damiano Lironi
Simona Radutoiu
Jens Stougaard
Original Assignee
Univ Aarhus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aarhus filed Critical Univ Aarhus
Publication of PY2139366A publication Critical patent/PY2139366A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
    • A01H1/10—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits
    • A01H1/101—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine
    • A01H1/102—Processes for modifying non-agronomic quality output traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine or caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Los aspectos de la presente invención hacen referencia a recptores de LysM genéticamente modificados. En particular, la presente invención se refiere al reemplazo de parte o todos los motivos en el dominio LysM1 por los correspondientes motivos del dominio LysM1 de un receptor de LysM donante que puede alterar la afinidad, selectividad, y/o especificidad por un oligosacárido, en particular por factores Nod (lipo-quito-olisacáridos(LCO)). La presente invención además se refiere a la alteración genética de receptores de LysM en plantas para incluir un dominio LysM1 modificado y para alterar genéticamente los receptores de LysM en plantas mediante el reemplazo de parte o todos los motivos en el dominio LysM1. La presente invención además se refiere a la combinación de modificaciones del dominio LysM1 como modificaciones de los dominios LysM2 para incluir un parche hidrofóbico, por medio de lo cual las modificaciones de dominio LysM2 pueden alterar la afinidad, selectividad, y/o especificidad por un oligosacárido, en particular por factores Nod (Lipo-quito-ologosacáridos(LCO)).-
PY202102139366A 2020-05-19 2021-05-19 Receptores de motivos de lisina PY2139366A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063027151P 2020-05-19 2020-05-19

Publications (1)

Publication Number Publication Date
PY2139366A true PY2139366A (es) 2022-05-10

Family

ID=76181080

Family Applications (1)

Application Number Title Priority Date Filing Date
PY202102139366A PY2139366A (es) 2020-05-19 2021-05-19 Receptores de motivos de lisina

Country Status (10)

Country Link
US (1) US20210363200A1 (es)
EP (1) EP4153731A1 (es)
CN (1) CN116323952A (es)
AR (1) AR122130A1 (es)
AU (1) AU2021274836A1 (es)
BR (1) BR112022023269A2 (es)
CA (1) CA3178790A1 (es)
PY (1) PY2139366A (es)
UY (1) UY39223A (es)
WO (1) WO2021233904A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116064565B (zh) * 2022-07-05 2024-10-25 中国水稻研究所 水稻OsCERK1基因在调控水稻对CuO NPs的耐受性中的应用
US20240344077A1 (en) * 2023-03-14 2024-10-17 Aarhus Universitet Genetically altered nfr1 receptor kinases
EP4680624A1 (en) * 2023-03-14 2026-01-21 Aarhus Universitet Genetically altered nfr5 receptor kinases

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4407956A (en) 1981-03-13 1983-10-04 The Regents Of The University Of California Cloned cauliflower mosaic virus DNA as a plant vehicle
CA1192510A (en) 1981-05-27 1985-08-27 Lawrence E. Pelcher Rna plant virus vector or portion thereof, a method of construction thereof, and a method of producing a gene derived product therefrom
NL8200523A (nl) 1982-02-11 1983-09-01 Univ Leiden Werkwijze voor het in vitro transformeren van planteprotoplasten met plasmide-dna.
US4536475A (en) 1982-10-05 1985-08-20 Phytogen Plant vector
EP0320500B1 (en) 1983-01-13 2004-11-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Non-oncogenic ti plasmid vector system and recombinant DNA molecules for the introduction of expressible genes into plant cell genomes
EP0131623B2 (en) 1983-01-17 1999-07-28 Monsanto Company Chimeric genes suitable for expression in plant cells
EP0160692A1 (en) 1983-11-03 1985-11-13 DE WET, Johannes Martenis Jacob Method for the transfer of exogenous genes in plants using pollen as a vector
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4615807A (en) 1985-07-23 1986-10-07 United States Environmental Resources, Corp. Method for wastewater treatment
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
ATE57390T1 (de) 1986-03-11 1990-10-15 Plant Genetic Systems Nv Durch gentechnologie erhaltene und gegen glutaminsynthetase-inhibitoren resistente pflanzenzellen.
EP0265556A1 (en) 1986-10-31 1988-05-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Stable binary agrobacterium vectors and their use
IL84459A (en) 1986-12-05 1993-07-08 Agracetus Apparatus and method for the injection of carrier particles carrying genetic material into living cells
ATE225853T1 (de) 1990-04-12 2002-10-15 Syngenta Participations Ag Gewebe-spezifische promotoren
ES2260886T3 (es) 1990-11-23 2006-11-01 Bayer Bioscience N.V. Procedimiento para transformar plantas monocotiledoneas.
JPH07505531A (ja) 1992-04-15 1995-06-22 プラント・ジェネティック・システムズ・エヌ・ブイ 単子葉植物細胞の形質転換法
US5633363A (en) 1994-06-03 1997-05-27 Iowa State University, Research Foundation In Root preferential promoter
DE69533037T2 (de) 1994-08-30 2005-05-04 Commonwealth Scientific And Industrial Research Organisation Pflanzentraskriptionsregulator von circovirus
EP0964927B1 (en) 1996-06-20 2012-11-07 The Scripps Research Institute Cassava vein mosaic virus promoters and uses thereof
DE69826596T2 (de) 1997-02-20 2006-02-09 Bayer Bioscience N.V. Verbesserte methode zur transformation von pflanzen
WO2000042207A2 (en) 1999-01-14 2000-07-20 Monsanto Technology Llc Soybean transformation method
CN1234869C (zh) 1999-05-19 2006-01-04 拜尔生物科学公司 农杆菌介导的棉花转化的改进方法
AU2002237224A1 (en) 2000-12-04 2002-06-18 Universiteit Utrecht A novel root specific promoter driving the expression of a novel LRR receptor-like kinase
EP1893760A1 (en) * 2005-06-08 2008-03-05 CropDesign N.V. Plants having improved growth characteristics and method for making the same
AU2006330817B2 (en) 2005-12-23 2012-07-19 Arcadia Biosciences, Inc. Nitrogen-efficient monocot plants
EP2176285A1 (en) 2007-07-27 2010-04-21 CropDesign N.V. Plants having enhanced yield-related traits and a method for making the same
FR2994793A1 (fr) * 2012-08-30 2014-03-07 Agronomique Inst Nat Rech Utilisation d'un recepteur kinase a motifs lysm pour ameliorer la reponse des plantes aux lipochitooligosaccharides.
BR112020003814A2 (pt) * 2017-08-25 2020-09-08 Centre National De La Recherche Scientifique plantas com metabolismo lipídico modificado e métodos para preparar as mesmas
AU2019321983B2 (en) * 2018-08-13 2025-11-20 Aarhus Universitet Genetically altered LysM receptors with altered agonist specificity and affinity

Also Published As

Publication number Publication date
EP4153731A1 (en) 2023-03-29
UY39223A (es) 2021-12-31
CN116323952A (zh) 2023-06-23
BR112022023269A2 (pt) 2022-12-20
AU2021274836A1 (en) 2023-01-05
US20210363200A1 (en) 2021-11-25
WO2021233904A1 (en) 2021-11-25
CA3178790A1 (en) 2021-11-25
AR122130A1 (es) 2022-08-17

Similar Documents

Publication Publication Date Title
PY2139366A (es) Receptores de motivos de lisina
CL2019002314A1 (es) Compuestos moduladores del receptor de hidrocarburos de arilo (ahr).
ECSP18060342A (es) Derivados de tiohidantoína sustituidos como antagonistas del receptor de andrógenos
NI201900076A (es) Compuestos moduladores del receptor de hidrocarburos de arilo (ahr)
CL2019001683A1 (es) Antagonistas de miostatina, activina o receptor de activina para el uso en el tratamiento de la obesidad y afecciones relacionadas.
CL2020001138A1 (es) Compuestos bicíclicos en puente como moduladores del receptor farnesoide x.
NI201900043A (es) Compuestos del péptido tirosina tirosina cíclico con anticuerpo acoplado como moduladores de receptores de neuropéptido y
BR112017000110A2 (pt) nuvem autoexpansível
CL2016000060A1 (es) Derivados piperidinil indol y su uso como inhibidores factor de complemento b.
BR112018017172A2 (pt) anticorpos monoclonais anti-alfa-sinucleína para prevenção da agregação de tau
MX2017003421A (es) Receptores de antigenos quimericos.
AR118785A1 (es) RECEPTORES DE LysM GENÉTICAMENTE ALTERADOS CON ESPECIFICIDAD Y AFINIDAD AGONISTAS ALTERADAS
UY36348A (es) Derivados de benzotiofenilo sustituidos como agonistas del gpr40 para el tratamiento de la diabetes tipo ii
UY37590A (es) COMPUESTOS MODULADORES DEL RECEPTOR DE HIDROCARBUROS ARÍLICOS (AhR)
CL2018003698A1 (es) Oligonucleótidos antisentido para modular la expresión de htra1.
BR112019005637A2 (pt) análogos da insulina com afinidade reduzida para o receptor de insulina e seu uso
UY40872A (es) Compuestos tricíclicos fusionados de piridazinona útiles para tratar infecciones de orthomyxovirus
DOP2016000212A (es) Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados
CL2016002809A1 (es) Compuestos derivados de pirrol, piridina o piperidina sustituidos con heterociclos, moduladores del receptor acoplado a la proteína g 40 (gpr40); composición farmacéutica que los comprende; y su uso para el tratamiento de enfermedades como diabetes, retinopatía, neuropatía, aterosclerosis, obesidad e hipertensión.
MX2022000945A (es) Composicion para incrementar la expresion de pgc-1alfa.
CL2020001140A1 (es) Compuestos espirocíclicos como moduladores del receptor farnesoide x.
MX2019003030A (es) Catalizador que contiene ni para la oligomerizacion de olefinas.
BR112019014963A8 (pt) Compostos-bis para dispositivos opticamente ativos
UY36209A (es) Derivados de la pirazina como agonistas moduladores del receptor gpr40 y composiciones farmacéuticas que los contienen
ECSP21003718A (es) Derivados de triazolquinoxalina adicionalmente sustituidos